Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7517
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder ; volume:19 ; number:1 ; day:28 ; month:10 ; year:2022 ; pages:1-11 ; date:12.2022
Harm reduction journal ; 19, Heft 1 (28.10.2022), 1-11, 12.2022
- Urheber
-
Eger, William H.
Altice, Frederick L.
Lee, Jessica
Vlahov, David
Khati, Antoine
Osborne, Sydney
Wickersham, Jeffrey A.
Bohonnon, Terry
Powell, Lindsay
Shrestha, Roman
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12954-022-00703-8
- URN
-
urn:nbn:de:101:1-2023011321164699687988
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Eger, William H.
- Altice, Frederick L.
- Lee, Jessica
- Vlahov, David
- Khati, Antoine
- Osborne, Sydney
- Wickersham, Jeffrey A.
- Bohonnon, Terry
- Powell, Lindsay
- Shrestha, Roman
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pre-Exposure Prophylaxis (PrEP)
P41 - Preexposure prophylaxis of infants’ food allergy
HIV Pre-exposure Prophylaxis in Germany: Barriers and Strategies to Improve Uptake
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
Pre-exposure prophylaxis against HIV: pros and cons
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies
Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa
Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
A qualitative study identifying implementation strategies using the i-PARIHS framework to increase access to pre-exposure prophylaxis at federally qualified health centers in Mississippi
Awareness of, willingness to use, and experiences with Pre-exposure prophylaxis among youth in Nigeria
Pre-Exposure Prophylaxis (PrEP)
P41 - Preexposure prophylaxis of infants’ food allergy
HIV Pre-exposure Prophylaxis in Germany: Barriers and Strategies to Improve Uptake
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
Pre-exposure prophylaxis against HIV: pros and cons
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies
Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa
Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
A qualitative study identifying implementation strategies using the i-PARIHS framework to increase access to pre-exposure prophylaxis at federally qualified health centers in Mississippi
Awareness of, willingness to use, and experiences with Pre-exposure prophylaxis among youth in Nigeria
Pre-Exposure Prophylaxis (PrEP)
P41 - Preexposure prophylaxis of infants’ food allergy
HIV Pre-exposure Prophylaxis in Germany: Barriers and Strategies to Improve Uptake
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
Pre-exposure prophylaxis against HIV: pros and cons
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies
Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa
Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
A qualitative study identifying implementation strategies using the i-PARIHS framework to increase access to pre-exposure prophylaxis at federally qualified health centers in Mississippi